Cocrystal Pharma (COCP) Other Non-Current Liabilities (2011 - 2019)
Cocrystal Pharma (COCP) reported Other Non-Current Liabilities of $90000.0 for Q3 2019, down 43.4% on a YoY basis from $159000.0 in Q3 2018, and down 26.83% sequentially from $123000.0 in Q2 2019.
Cocrystal Pharma (COCP) Other Non-Current Liabilities (2011 - 2019) Analysis & Trends
Cocrystal Pharma (COCP) has 6 years of Other Non-Current Liabilities data on file, last reported at $90000.0 in Q3 2019.
- For the quarter ending Q3 2019, Other Non-Current Liabilities fell 43.4% year-over-year to $90000.0; the trailing twelve-month figure through Sep 2019 stood at $90000.0 (down 43.4% YoY), and the FY2018 full-year result was $263000.0, down 53.78% from the prior year.
- Other Non-Current Liabilities slipped to $90000.0 in Q3 2019, from $123000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $4.1 million in Q4 2015 to a low of $90000.0 in Q3 2019.
- A 5-year average of $972000.0 and a median of $416000.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 81.4% in 2018 and slumped 43.4% in 2019, its largest moves.
- Tracing COCP's Other Non-Current Liabilities over 5 years: stood at $4.1 million in 2015, then tumbled by 64.13% to $1.5 million in 2016, then tumbled by 61.45% to $569000.0 in 2017, then tumbled by 53.78% to $263000.0 in 2018, then tumbled by 65.78% to $90000.0 in 2019.
- Business Quant data shows COCP's Other Non-Current Liabilities at $90000.0 in Q3 2019, $123000.0 in Q2 2019, and $163000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 90,000.00 |
| Jun 30, 2019 | 123,000.00 |
| Mar 31, 2019 | 163,000.00 |
| Dec 31, 2018 | 263,000.00 |
| Sep 30, 2018 | 159,000.00 |
| Dec 31, 2017 | 569,000.00 |
| Sep 30, 2017 | 855,000.00 |
| Dec 31, 2016 | 1.48 Mn |
| Sep 30, 2016 | 1.91 Mn |
| Dec 31, 2015 | 4.12 Mn |
| Jun 30, 2011 | -1,672.00 |